Phase 3 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who fully understand the study, are willing to follow the trial procedures, and agree to sign a consent form
- People who are 12 years of age or older, of any gender, at the time of signing the consent form
- People who have been diagnosed with atopic dermatitis (eczema) according to a standard set of medical diagnostic criteria called the Hanifin-Rajka criteria
Who may not be able to join:
- People whose atopic dermatitis has been considered unstable by the study doctor in the two weeks before the study start — for example, if the condition has been clearing up on its own or getting worse very quickly
- People whose skin symptoms at the time of screening and study start are only on the hands or feet, with no history of symptoms in other typical areas such as the face or skin folds
- People who have skin damage or differences in the affected area — such as significant scarring, tattoos, or changes in skin colour — that could make it difficult to assess the study treatment's effects
- People who have other skin conditions at the time of screening and study start that could affect how the treatment is assessed, such as psoriasis, acne, skin cancer, widespread redness of the skin, or Netherton syndrome
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: qianjin Lu, Chinese Academy of Medical Sciences Hospital for Skin Disease
Phone: +8615358160458
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of subjects achieving an Investigator's Global Assessment (IGA) response (defined as an IGA score of 0 or 1 with a reduction of ≥2 points from baseline)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.